Αναζήτηση Δραστικών

IMIGLUCERASE

ATC

Εμπορικές Ονομασίες

  • DRUGBANK - Imiglucerase
  • indication:

    For the treatment of Gaucher's disease (deficiency in glucocerebrosidase)

  • pharmacology:

  • mechanism:

    Imiglucerase catalyzes the hydrolysis of the glycolipid, glucocerebroside, to glucose and ceramide as part of the normal degradation pathway for membrane lipids.

  • toxicity:

  • absorprion:

  • halflife:

    3.6-10.4 min

  • roouteelimination:

  • volumedistribution:

    * 0.09 to 0.15 L/kg

  • clearance:

    * 14.5 +/- 4.0 mL/min/kg